During the past decade, Meriter Wisconsin Heart conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meriter Wisconsin Heart" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Bard Ltd" with 1 trials as a collaborator, "Boston Medical Center" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Meriter Wisconsin Heart" are "LMNA-Related Dilated Cardiomyopathy" (2 trials), "Critical Limb Ischemia" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Meriter Wisconsin Heart" in a lesser frequency.

Most popular intervention types in "Meriter Wisconsin Heart" are "Drug" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARRY-371797, p38 inhibitor, oral" (1 trials), "ARRY-371797, p38 inhibitor; oral" (1 trials), "Empagliflozin" (1 trials), "Endovascular revascularization" (1 trials) and "Open surgical revascularization" (1 trials). Other intervention names were less common.

The vast majority of trials in "Meriter Wisconsin Heart" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Meriter Wisconsin Heart". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Meriter Wisconsin Heart, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Meriter Wisconsin Heart, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".